US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Mar 24, 2026 (5 months ago)

GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of particulate matter

What was recalled

GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63.

Recalling firm
GE Healthcare Ireland Limited
NDC code
0407-1413-63
Origin
Ireland
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0447-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Iohexol recalls

See all